Abstract：Objective To investigate the effect of Neuman intervention model in patients with hyperglycemia after liver transplantation. Methods From January 2018 to January 2019, 86 patients with liver transplantation admitted to Nanjing Drum Tower Hospital of Nanjing University Medical College were selected and divided into control group and observation group by random number table method, 43 in each group. The control group was given routine intervention mode, while the observation group was given Neuman intervention mode. The blood sugar control, the change of treatment-related indicators and the incidence of postoperatre complications and familys′ satisfaction were compared between the two groups. Results After intervention, fasting blood glucose and 2 h postprandial blood glucose levels in both groups were lower than those before intervention, and the observation group was lower than the control group, with high statistically significant differences (P ＜ 0.01); the incision healing time, blood glucose compliance time, and hospital stay time of observation group were all shorter than the control group, and the insulin consumption was lower than that of the control group when the blood glucose reached the standard, the differences were statistically significant (all P ＜ 0.01); the incidence of postoperative complications in the observation group was less than in the control group, the difference was statistically significant (P ＜ 0.05). The satisfaction of the family in observation group was higher than the control group, and the difference was statistically significant (P ＜ 0.05). Conclusion Neuman intervention model can effectively control the blood sugar of patients after liver transplantation, improve the changes of treatment-related indicators, and reduce the incidence of postoperative complications, it is worth promoting.
周利平 崔恒▲ 盛俊 胡婕 夏雪峰. Neuman干预模式在肝移植术后高血糖患者中的应用效果[J]. 中国医药导报, 2020, 17(28): 155-158.
ZHOU Liping CUI Heng▲ SHENG Jun HU Jie XIA Xuefeng. Application effect of Neuman intervention model in patients with hyperglycemia after liver transplantation. 中国医药导报, 2020, 17(28): 155-158.
[1] 徐琪.护理干预对肝移植术后患者肺部真菌感染的观察[J].中国卫生标准管理，2019，10（4）：165-167.
[2] 解恩博，轩凤慧，孙晓东，等.肝移植术后早期并发症的危险因素分析[J].临床肝胆病杂志，2018，34（6）：1282-1288.
[3] 吴英，任辉，廖睿，等.同伴支持对肝移植术后患者心理及生活质量的影响[J].中国护理管理，2018，18（12）：1700-1704.
[4] Niazi S，Schneekloth T，Taner CB. Elderly recipients of liver transplantation：impact of age and psychosocial variables on outcome [J]. Curr Opin Organ Transplant，2017， 22（6）：588-592.
[5] 成建斌，江雪梅，刘鹏，等.肝癌肝移植术后复发的干预措施疗效评价：网状荟萃分析[J].中华移植杂志：电子版，2018，12（4）：183-187.
[6] 冷艳娜，王瑜贵，雷联会，等.Neuman护理模式对肝移植术后患者血糖控制的影响[J].齐鲁护理杂志，2018，24（6）：74-76.
[7] 胡维昱，王建红，胡骁，等.肝移植术后中期肝脏血流动力学与肝功能异常的关系[J].器官移植，2016，7（4）：296-300.
[8] Samuel D，Coilly A. Management of patients with liver diseases on the waiting list for transplantation：a major impact to the success of liver transplantation [J]. BMC Med，2018，16（1）：113.
[9] 樊嘉，史颖弘，田孟鑫.肝癌肝移植术后肿瘤复发的防治策略[J].中华消化外科杂志，2019，18（1）：20-23.
[10] 孟稼祥，万平，薛峰，等.儿童肝移植术后病原菌感染的危险因素分析[J].肝胆外科杂志，2017，25（6）：412-415.
[11] 吕少诚，王苑，潘冰，等.肝移植术后肺部感染的诊治及其危险因素[J].中华肝胆外科杂志，2018，24（6）：371-375.
[12] 李彩霞，卢惠娟，徐建鸣，等.肝移植术后代谢并发症危险因素及管理措施的研究进展[J].护理研究，2017，31（20）：2433-2436.
[13] Jackson KR，Cameron A. Liver Transplantation：Candidate Selection and Organ Allocation in the United States [J]. Int Anesthesiol Clin，2017，55（2）：5-17.
[14] 陆建文，董健，张谞丰，等.肠道微生态与肝移植及肝移植术后缺血性胆道病变的关系[J].器官移植，2016，7（4）：315-319.
[15] 王海清，李磊，杨家印.肝癌肝移植术后的复发机制与防治策略[J].中华肝脏病杂志，2018，26（2）：93-97.
[16] 陈榕，江涛，张冬华，等.原发性肝癌患者肝移植术后无激素免疫抑制方案的临床疗效[J].中华肝胆外科杂志，2017，23（9）：602-606.
[17] Lieber SR，Schiano TD，Rhodes R. Should living donor liver transplantation be an option when deceased donation is not [J]. J Hepatol，2018，68（5）：1076-1082.
[18] 王海.临床护理协调员在小儿亲体肝移植中的作用[J].上海护理，2018，18（1）：57-58.
[19] 唐绪容，周蓉，屈虹，等.肝移植患儿术中压力性损伤发生特征及影响因素分析[J].中国护理管理，2019，19（8）：1153-1158.
[20] 韩永仕，韦中余，张蓉.成人原位肝移植术后早期急性肺损伤危险因素的临床研究[J].中国医药导报，2016， 13（20）：124-127.
[21] 孟繁秀，徐钧.肝移植术后早期急性肾功能损伤的研究现状[J].中国现代医生，2018，56（1）：159-164.
2020, Vol. 17 
京公网安备 11010502046598号